• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

第三代头孢菌素:临床使用10年后的安全性概况。

Third generation cephalosporins: safety profiles after 10 years of clinical use.

作者信息

Neu H C

机构信息

Department of Medicine, College of Physicians & Surgeons, Columbia University, New York, New York 10032.

出版信息

J Clin Pharmacol. 1990 May;30(5):396-403. doi: 10.1002/j.1552-4604.1990.tb03476.x.

DOI:10.1002/j.1552-4604.1990.tb03476.x
PMID:2189900
Abstract

Compared with aminoglycosides, chloramphenicol, sulfonamides, tetracyclines, and even penicillins, the cephalosporins represent a remarkably safe class of antibiotics. Among the cephalosporins, the extended spectrum, third generation agents developed generally produce few side effects and appear to be less allergenic than the penicillins. Nephrotoxicity has not been a problem at recommended doses. Some third generation agents can cause hypoprothrombinemia if not administered with vitamin K, and disulfiram-like reactions occur with some agents because of the presence of a thiomethyl tetruzole moiety affixed to the cephem nucleus. There is a greater incidence of diarrhea associated with the agents excreted through a primarily biliary route, and this may contribute to the selection of drug resistant bacteria. Some agents are less active against staphylococci and their use may result in an increased incidence of superinfection or overgrowth of enterococci. If attention is given to the potential for adverse effects, many of these problems can be avoided and the third generation cephalosporins can be used safely in hospitals, nursing homes, and home care settings.

摘要

与氨基糖苷类、氯霉素、磺胺类、四环素类甚至青霉素类相比,头孢菌素类是一类安全性非常高的抗生素。在头孢菌素类中,一般所研发的广谱第三代药物副作用很少,而且似乎比青霉素类的致敏性更低。在推荐剂量下,肾毒性并非问题。一些第三代药物如果不与维生素K一起使用,可能会导致低凝血酶原血症,并且由于头孢烯核上连接有硫代甲基四氮唑部分,一些药物会出现双硫仑样反应。主要通过胆汁途径排泄的药物所引起的腹泻发生率更高,这可能会促使耐药菌的产生。一些药物对葡萄球菌的活性较低,使用它们可能会导致二重感染或肠球菌过度生长的发生率增加。如果关注到这些潜在的不良反应,许多问题是可以避免的,第三代头孢菌素类药物可以在医院、疗养院和家庭护理环境中安全使用。

相似文献

1
Third generation cephalosporins: safety profiles after 10 years of clinical use.第三代头孢菌素:临床使用10年后的安全性概况。
J Clin Pharmacol. 1990 May;30(5):396-403. doi: 10.1002/j.1552-4604.1990.tb03476.x.
2
Third-generation cephalosporins: a critical evaluation.第三代头孢菌素:批判性评价
Clin Pharm. 1984 Jul-Aug;3(4):351-73.
3
Antibiotic use in neonatal sepsis.新生儿败血症中的抗生素使用。
Turk J Pediatr. 1998 Jan-Mar;40(1):17-33.
4
Side effects of cephalosporins.头孢菌素的副作用。
Drugs. 1987;34 Suppl 2:105-20. doi: 10.2165/00003495-198700342-00009.
5
Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.头孢唑肟:抗菌活性、药代动力学特性及治疗用途综述
Drugs. 1985 Apr;29(4):281-329. doi: 10.2165/00003495-198529040-00001.
6
Cephalosporin antibiotics.
Mayo Clin Proc. 1983 Feb;58(2):79-87.
7
[Tolerable and intolerable side effects of antibiotic therapy].[抗生素治疗的可耐受和不可耐受副作用]
Monatsschr Kinderheilkd. 1984 Oct;132(10):760-4.
8
Cephalosporin-induced hypoprothrombinemia: is the N-methylthiotetrazole side chain the culprit?头孢菌素诱导的低凝血酶原血症:N-甲基硫代四唑侧链是罪魁祸首吗?
Antimicrob Agents Chemother. 1986 Jun;29(6):1108-9. doi: 10.1128/AAC.29.6.1108.
9
Antimicrobial therapy in dialysis patients. I. Penicillins and cephalosporins.
Blood Purif. 1985;3(1-3):94-103. doi: 10.1159/000169402.
10
[Selection of antibiotics and practice and the clinic].[抗生素的选择、实践与临床]
Schweiz Med Wochenschr. 1982 Mar 13;112(11):358-62.

引用本文的文献

1
Physiologically Based Pharmacokinetic Model of Cefotaxime in Patients with Impaired Renal Function.肾功能受损患者头孢噻肟的生理药代动力学模型
Clin Pharmacokinet. 2025 Feb;64(2):257-273. doi: 10.1007/s40262-024-01469-x. Epub 2025 Jan 7.
2
Cefoperazone and sulbactam-related eosinophilic peritonitis: a case report and literature review.头孢哌酮舒巴坦相关嗜酸性粒细胞性腹膜炎:一例报告及文献复习。
J Int Med Res. 2021 Jun;49(6):3000605211025367. doi: 10.1177/03000605211025367.
3
Population Pharmacokinetics of Cefotaxime and Dosage Recommendations in Children with Sickle Cell Disease.
头孢噻肟的群体药代动力学及镰状细胞病儿童的剂量推荐。
Antimicrob Agents Chemother. 2018 Mar 27;62(4). doi: 10.1128/AAC.00637-17. Print 2018 Apr.
4
A New Structure-Activity Relationship (SAR) Model for Predicting Drug-Induced Liver Injury, Based on Statistical and Expert-Based Structural Alerts.一种基于统计和专家结构警示的预测药物性肝损伤的新结构-活性关系(SAR)模型
Front Pharmacol. 2016 Nov 22;7:442. doi: 10.3389/fphar.2016.00442. eCollection 2016.
5
Antimicrobial activity of ceftriaxone compared with cefotaxime in the presence of serum albumin.在血清白蛋白存在的情况下头孢曲松与头孢噻肟的抗菌活性比较。
Can J Infect Dis. 1995 Jan;6(1):21-7. doi: 10.1155/1995/617610.
6
Pharmacological properties of parenteral cephalosporins: rationale for ambulatory use.胃肠外头孢菌素类药物的药理学特性:门诊使用的理论依据。
Drugs. 2000;59 Suppl 3:9-18; discussion 47-9. doi: 10.2165/00003495-200059003-00002.
7
Cephalosporin utilisation review and evaluation.头孢菌素使用情况回顾与评估
Pharmacoeconomics. 1995 Aug;8(2):100-22. doi: 10.2165/00019053-199508020-00003.
8
Drug utilisation review (DUR) of the third generation cephalosporins. Focus on ceftriaxone, ceftazidime and cefotaxime.第三代头孢菌素的药物利用评价。重点关注头孢曲松、头孢他啶和头孢噻肟。
Drugs. 1995 Sep;50(3):423-39. doi: 10.2165/00003495-199550030-00002.
9
Cefotaxime desensitization.头孢噻肟脱敏疗法。
Clin Investig. 1993 Feb;71(2):165-7. doi: 10.1007/BF00180000.
10
Cefepime clinical pharmacokinetics.头孢吡肟的临床药代动力学。
Clin Pharmacokinet. 1993 Aug;25(2):88-102. doi: 10.2165/00003088-199325020-00002.